Sign up
Pharma Capital

McCarthy & Stone appoints new dual chief operating officers

Turner will be in charge of the group's building operations and Lloyd will oversee its customer-facing services
1544167872_lewsey-court-tetbury-retirement-living-(1).jpg
The developer and manager of retirement communities said the new COO's would join the board on 1 Jan 2019

McCarthy & Stone PLC (LON:MCS) said on Friday it had appointed Nigel Turner and Mike Lloyd to its board as dual chief operating officers. 

The developer and manager of retirement communities said the pair would oversee the group's building operations and customer-facing services respectively and help deliver the group's new strategy.

READ: McCarthy & Stone shares slide as annual profits plunge

The company said Turner would join as chief operating officer in charge of the group's building operations and that Lloyd would be in charge of the group's customer-facing services. 

The pair will join the board on 1 January 2019.

"We are delighted to announce these two senior appointments to the board.  Nigel and Mike's experience will significantly strengthen our management team and ensure we align our new strategy with operational execution and excellence,” said John Tonkiss, McCarthy & Stone’s CEO said in a statement.



Register here to be notified of future MCS Company articles
View full MCS profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.